Bounce Mobile Systems Inc. (BNCM) announced its merger with DELEX Healthcare Group Inc. (DELEX) on July 2, 2024 to drive their expansion and growth plans. BNCM shares have increased over 600% since the announcement of the merger

Reno, Nevada, United States, 27th Sep 2024 – Bounce Mobile Systems Inc. (BNCM) announced its merger with DELEX Healthcare Group Inc. (DELEX) on July 2, 2024 to drive their expansion and growth plans. BNCM shares have increased over 600% since the announcement of the merger. DELEX is a Delaware-registered company, and the holding company of DLX Holdings, Inc. (DLX). DLX is a Philippine-based parent company that holds a 60% controlling interest in DELEX Pharma International, Inc.

A Promising Future

This merger between DELEX and BNCM marks a pivotal milestone for both parties. DELEX is prepared to continue its expansion by developing a broader range of products, expanding global distribution channels, and consistently leading the market in delivering quality and cost-effective medicines and medical devices to its clients.

With the government’s continued support in fostering growth and competitiveness of the healthcare industry, and leveraging the combined expertise of both companies, the merger is set to achieve new heights in the coming years. This merger promises significant benefits to current and future investors and shareholders, enhancing the company’s financial stability and growth prospects while generating greater returns and value for their investments.

Announcements

BNCM and DELEX has made various announcements as stated below.
Further details can be found here –  https://www.bncm.net/

1. Post Management Plans

A. Management Transfer 
B. Asset Transfer
C. Expansion Plans

2. Expansion Plans

A. Introduce New Product Lines
B. Expand DELEX Pharmacy
C. Expand Distribution Networks
D. Partnerships with Manufacturers
E. Partnerships with Healthcare Providers

3. DELEX launched 11 New Products to Propel Growth

DELEX Pharma has launched an impressive array of 11 new pharmaceutical products in the first half of 2024, setting the stage for significant growth across multiple therapeutic areas. This launch reflects DELEX Pharma’s commitment to addressing critical healthcare needs in the Philippines, particularly in the fields of critical care, oncology, anesthesia, and medical devices.

4. DELEX Expand its Medical Device Business

DELEX PHARMA is expanding its medical device business through its strategic partnerships with leading international medical device companies in the US and Germany. These collaborations are expected to contribute around 30% of the company’s total revenue, reinforcing DELEXs rapid growth in the healthcare sector.

5. DELEX ICU Forum has reached almost 200,000 Healthcare Professionals Worldwide

DELEX ICU (Intensive Care Unit) Forums have reached a global audience of almost 200,000 healthcare professionals worldwide.

6. DELEX Acquires JMN Brothers Pharma

DELEX Pharma has acquired JMN Brothers Pharma Limited, Inc. (JMN Pharma) in 2022. JMN Pharma, established in 2018, is known for its expertise in women’s health and beauty, along with its ethical business in hospital products. 

7. DELEX Continued ISO-9001-2015 Certification

DELEX Pharma has once again demonstrated its unwavering commitment to quality and customer satisfaction by successfully passing the ISO 9001:2015 re-certification audit. The evaluation, conducted by Certification Partner Global (CPG), a leading international auditing firm, took place on July 12, 2024. The certification also marks a significant milestone in the company’s journey toward operational excellence.   

About Bounce Mobile Systems, Inc. (OTC: BNCM)

BNCM is an Asset Management Company that secures its assets by investing in companies with strong growth potentials, robust revenues, significant profits, proven track records, and promising business models with highly experienced management teams that will exceptionally qualify for quotation and listing on the OTC or NASDAQ markets within the next 2 to 3 years. The growth of these companies will directly provide more employment opportunities to the communities, improve the country’s economy, and bring greater social change.

For more information, visit – https://www.bncm.net/
 

About Delex Healthcare Group, Inc. (DELEX)

DELEX is a Delaware-registered company, and the holding company of DLX Holdings, Inc. (DLX). DLX is a Philippine-based parent company that holds a 60% controlling interest in Delex Pharma International, Inc. an ISO 9001-2015 Certified company, which also holds a controlling interest in JMN Brother’s Pharma Limited, Inc. DLX and its subsidiaries are involved in the development and distribution of pharmaceutical and healthcare products in the Philippines.

For more information, visit – https://delexhealth.com 

Disclaimer: Forward-Looking Statements

Certain information set forth by BNCM-DELEX group through presentation and publishing including those in websites and in other platforms may contain “forward-looking information,” including “future-oriented financial information,” and “financial outlook,” under applicable securities laws. These statements may contain information about financial prospects, projections, economic conditions, trends and uncertainties, and involve risks. We caution that actual results could differ materially from management experts, depending on the outcome of certain factors. Forward looking statements are provided to understand company’s beliefs and opinions in respect of the future so that they may use such beliefs and opinions as one factor in evaluating an investment. Any or all forward-looking statements may or may not turn to be wrong thereby making these statements of no guarantee into its future performance and undue reliance should not be placed on them. Such forward-looking statements necessarily involve known and unknown risks and uncertainties which may cause variations in actual performance in future periods and may differ materially from any projections of future performance or results expressed or implied by such forward-looking statements, thus speaks only as of the date they are made. The Company undertakes no obligation to update or revise forward-looking statements except as required by applicable securities laws.

Media Contact

Organization: BNCM Inc.

Contact Person: Kathleen Galvez

Website: https://bncm.net

Email: Send Email

Contact Number: +17753913237

Address: 401 Ryland Street, Suite 200-A Reno, NV 89502 United States

City: Reno

State: Nevada

Country: United States

Release Id: 27092417496

The post BNCM ANNOUNCES MERGER WITH DELEX HEALTHCARE. SHARES UP BY 600% appeared on King Newswire. It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it.